Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.

    PTC-AADC Shows Benefits for Patients with AADC Deficiency, Data Shows

    Recently, biopharmaceutical company PTC Therapeutics, Inc. performed a five-year data analysis to evaluate the continued safety, efficacy, and tolerability of PTC-AADC. The company developed this novel gene therapy to improve…

    Continue Reading PTC-AADC Shows Benefits for Patients with AADC Deficiency, Data Shows
    TAVNEOS Approved in Japan for ANCA-Associated Vasculitis
    Source: https://unsplash.com/photos/ZHys6xN7sUE

    TAVNEOS Approved in Japan for ANCA-Associated Vasculitis

    Sometimes, certain drugs may be approved in different countries and not in others. However, drug approval spanning multiple countries highlights the importance of getting drugs and treatments into the hands…

    Continue Reading TAVNEOS Approved in Japan for ANCA-Associated Vasculitis